Orihashi K, Sueda T, Watari M, Okada K, Ishii O, Matsuura Y
First Department of Surgery, Hiroshima University School of Medicine, Kasumi 1-2-3, Minami-ku, 734-8551, Hiroshima, Japan.
Eur J Cardiothorac Surg. 2001 Nov;20(5):973-8. doi: 10.1016/s1010-7940(01)00909-5.
We have experienced transaortic stent-grafting for treating distal arch aneurysm or type B dissection. This paper is to mainly report the surgical aspect of these procedures.
Fifteen patients underwent this surgery, including 12 men and three women ranging from 47 to 83 years. Twelve had aneurysms and three aortic dissection. Concomitant surgery was necessary in seven patients (coronary artery bypass grafting in five, tricuspid annuloplasty in one, and replacement of ascending aorta and/or total arch replacement in three cases). A stent graft (Gianturco Z-stent and Intervascular prosthesis) was loaded in a 30-F sheath catheter. Under circulatory arrest, selective cerebral perfusion was established, and the sheath catheter was inserted through aortotomy into descending aorta and the stent graft was deployed at an appropriate level. The proximal end of graft was sutured to the aorta just distal to the left subclavian artery with inclusion method at the posterior wall. Concomitant surgery was done during cooling or rewarming period. TEE was utilized to visualize every endovascular manipulation to avoid unintended intimal injury or misplacement of graft and to assess the surgical results in the operative theater.
Aneurysm was successfully excluded except in one patient who had a proximal endoleak and distal endoleak due to underestimation of aortic diameter. There was one operative mortality caused by cerebral infarction, possibly due to debris from femoral arterial cannulation. In the remaining patients, there was no enlargement of residual aneurysm. The excluded aneurysmal sac gradually regressed and disappeared within 2 years in five patients and the thrombosed false lumen completely shrunk within 1 year in two patients. One patient had paraplegia, possibly because the graft was intentionally advanced deeply to cover the thick and fragile atheromatous layer in order to avoid destruction of the atheroma by an expanded graft.
Endovascular stent graft via the aortic arch is an acceptable treatment for distal arch aneurysms close to or involving left subclavian artery or type B dissections, especially for those cases requiring other cardiac procedures. It can lead to regression and disappearance of aneurysm or dissection in the mid-term follow-up.
我们已采用经主动脉支架植入术治疗远端主动脉弓动脉瘤或B型夹层。本文主要报告这些手术的外科操作方面。
15例患者接受了该手术,其中男性12例,女性3例,年龄在47至83岁之间。12例为动脉瘤,3例为主动脉夹层。7例患者需要同期手术(5例行冠状动脉旁路移植术,1例行三尖瓣成形术,3例行升主动脉置换和/或全主动脉弓置换)。将一个支架移植物(Gianturco Z形支架和血管内假体)装载到一根30F鞘管中。在循环停止下,建立选择性脑灌注,通过主动脉切开术将鞘管插入降主动脉,并在适当水平释放支架移植物。移植物的近端用包埋法缝合到左锁骨下动脉远端的主动脉后壁。同期手术在降温或复温期间进行。术中使用经食管超声心动图(TEE)观察每一次血管内操作,以避免意外的内膜损伤或移植物误置,并在手术台上评估手术结果。
除1例因主动脉直径估计不足出现近端内漏和远端内漏的患者外,动脉瘤均成功排除。有1例患者因脑梗死死亡,可能是由于股动脉插管产生的碎片所致。其余患者中,残余动脉瘤无增大。5例患者中,被排除的动脉瘤囊在2年内逐渐缩小并消失,2例患者中,血栓形成的假腔在1年内完全缩小。1例患者出现截瘫,可能是因为为了避免扩张的移植物破坏动脉粥样硬化斑块,有意将移植物深入推进以覆盖厚且易碎的动脉粥样硬化层。
经主动脉弓的血管内支架移植物是治疗靠近或累及左锁骨下动脉的远端主动脉弓动脉瘤或B型夹层的一种可接受的治疗方法,特别是对于那些需要进行其他心脏手术的病例。在中期随访中,它可导致动脉瘤或夹层缩小并消失。